NX-1607 drug page Clinical trials

Trials with NX-1607

Every colorectal cancer trial that includes this drug. Those looking for patients come first.

1Trials
1Recruiting
2Countries
345Planned patients

Showing 1–1 of 1

A Study of NX-1607 in Adults With Advanced Malignancies
Recruiting Phase 1 345 patients NCT05107674

This is a first-in-human Phase 1a/1b multicenter, open-label oncology study designed to evaluate the safety and anti-cancer activity of NX-1607 in patients with advanced malignancies.

United States, United Kingdom Sept 2021 – Feb 2028 Interventional
Combined with: Paclitaxel

Where the recruiting trials are